Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties Track

FDG dose reduction for PET/MR examinations in patients with Crohn's disease- how low can you go?

Minnie Kieler, Jessica Robbins, David Kim, Alan McMillan, Sumona Saha, Freddy Caldera, Christine Jaskowiak, William Natividad and Scott Perlman
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 166;
Minnie Kieler
2Radiology University of Wisconsin School of Medicine and Public Health Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica Robbins
2Radiology University of Wisconsin School of Medicine and Public Health Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Kim
2Radiology University of Wisconsin School of Medicine and Public Health Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan McMillan
2Radiology University of Wisconsin School of Medicine and Public Health Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sumona Saha
1Medicine University of Wisconsin School of Medicine and Public Health Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Freddy Caldera
1Medicine University of Wisconsin School of Medicine and Public Health Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine Jaskowiak
2Radiology University of Wisconsin School of Medicine and Public Health Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Natividad
2Radiology University of Wisconsin School of Medicine and Public Health Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Perlman
2Radiology University of Wisconsin School of Medicine and Public Health Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

166

Introduction: PET/MR is a promising hybrid imaging modality for the evaluation of disease activity in Crohn's disease. It combines both PET metabolic information, using state-of-the-art high sensitivity digital PET detectors, and MRI high soft tissue contrast resolution, which can be useful in distinguishing fibrotic and inflammatory strictures to help guide treatment. The aim of this study is to determine if reduced-dose PET acquisitions, simulated by a short PET acquisition time, would provide similar diagnostic information to a 5-minute image acquisition.

Methods: Twenty patients with Crohn's disease had PET/MR exams (Signa PET/MR, GE Healthcare) of the abdomen to evaluate bowel disease. Exams were performed using 5mCi (+/- 10%) of FDG and standard PET/MR bowel technique. Simulated low-dose acquisitions of 1, 2, 3 and 4 minutes were reviewed in a random order and compared to a 5-minute image. Two nuclear medicine readers were blinded to the length of each image, and rated the image quality of the bowel and bone marrow using the 5-minute image as the standard reference, using the scale: 1=image quality equal to the 5-minute image; 2=slightly reduced image quality; 3=significantly reduced image quality; 4=non-diagnostic. A score of 1 & 2 indicated image quality was adequate for image interpretation. Results: Nearly all the 3 and 4 minute images were considered to have adequate quality for image interpretation relative to the standard reference 5-minute image (Bowel rated a 1 or 2: (Reader 1: 20/20; Reader 2: 20/20). Bone marrow: (Reader 1: 20/20; Reader 2: 19/20). Ratings for the image quality of the 2-minute images were much lower compared to the standard: Bowel score of 1 or 2: (Reader 1: 7/20; Reader 2: 7/20) Bowel score of 3: (Reader 1: 12/20; Reader 2: 13/20). Bone marrow score of 1 or 2: (Reader 1: 8/20; Reader 2: 8/20). Most ratings for the 1-minute images were considered non-diagnostic for bowel or bone marrow evaluation: Bowel score 4: (Reader 1: 20/20; Reader 2: 19/20). Bone marrow score 4: (Reader 1: 19/20; Reader 2: 18/20). There was a significant difference in the bowel image quality when the 3 and 4 minute acquisitions were compared to the 2-minute acquisitions (p<.0001, Fishers exact test). There was excellent inter-observer agreement between both readers across all categories.Conclusion: The evaluation of the PET/FDG image quality in patients with Crohn's disease performed on a state-of-the-art PET/MR scanner with high-sensitivity digital PET detectors suggests that image acquisition time can be reduced by 40% without a loss in diagnostic quality. More importantly, the dose of FDG can be reduced by 40% (to 3 mCi) thus significantly decreasing radiation exposure to this predominantly young patient population.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 59, Issue supplement 1
May 1, 2018
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
FDG dose reduction for PET/MR examinations in patients with Crohn's disease- how low can you go?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
FDG dose reduction for PET/MR examinations in patients with Crohn's disease- how low can you go?
Minnie Kieler, Jessica Robbins, David Kim, Alan McMillan, Sumona Saha, Freddy Caldera, Christine Jaskowiak, William Natividad, Scott Perlman
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 166;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
FDG dose reduction for PET/MR examinations in patients with Crohn's disease- how low can you go?
Minnie Kieler, Jessica Robbins, David Kim, Alan McMillan, Sumona Saha, Freddy Caldera, Christine Jaskowiak, William Natividad, Scott Perlman
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 166;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties Track

  • Quantitative Evaluation of Parathyroid Adenoma and Hyperplasia in Reference to Thyroid using Tc-99m MIBI SPECT/CT
  • A primitive study for clinical application of 18F-AlF-NOTA-octreotide PET/CT in combination with 18F-FDG PET/CT for imaging neuroendocrine neoplasms
  • Role of 18F-FDG PET/CT in detection of disease burden and response assessment in patients with myeloid sarcoma
Show more General Clinical Specialties Track

Gastroenterology

  • Liquid Gastric Emptying Study is often Abnormal after Normal Gastric Solid Emptying – Institutional Experience in a VA Hospital
  • Variability of DACS Antral Contraction Frequency and Ejection Fraction in Normals
  • Efficacy of Hepatobiliary Scintigraphy with 60-Minute Sincalide Infusion Rate in the Detection of Chronic Acalculous Cholecystitis
Show more Gastroenterology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire